Anaesthesia
Conditions
Interventions
Sponsors
Al Azhar University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ASA I and ASA II, scheduled for elective endoscopic nasal surgeries, were included in this study.
Exclusion criteria
Exclusion criteria: Patients with BMI more than 30 kg/m2. Patients with advanced respiratory, renal, hepatic, neurologic, or psychiatric disease. pregnant female. patients with history of allergy to any of the study drugs. patients using central nervous system depressants or analgesics over the previous 24 h. patients with expected difficulties in laryngoscopy and intubation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change on the visual analog scale (VAS) for pain (0 = no pain to 100 = the maximum pain )to assessment the duration of analgesia following the surgery. The VAS was used to measure the patients' pain at rest at the following intervals: 20 minutes, an hour, 2 hours, 4 hours, 8 hours, 16 hours, and 24 hours postoperatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total Ketorolac consumption . Ketorolac will be used intravenously if the visual analog scale ( VAS) score was >5 to control postoperative pain. | — |
Countries
Egypt
Contacts
Public ContactMahmoud Elbahrawy
Assistant Professor of Otorhinolaryngology
Outcome results
None listed